Literature DB >> 23795777

Nanoscale amphiphilic macromolecules with variable lipophilicity and stereochemistry modulate inhibition of oxidized low-density lipoprotein uptake.

Dawanne E Poree1, Kyle Zablocki, Allison Faig, Prabhas V Moghe, Kathryn E Uhrich.   

Abstract

Amphiphilic macromolecules (AMs) based on carbohydrate domains functionalized with poly(ethylene glycol) can inhibit the uptake of oxidized low density lipoprotein (oxLDL) and counteract foam cell formation, a key characteristic of early atherogenesis. To investigate the influence of lipophilicity and stereochemistry on the AMs' physicochemical and biological properties, mucic acid-based AMs bearing four aliphatic chains (2a) and tartaric acid-based AMs bearing two (2b and 2l) and four aliphatic chains (2g and 2k) were synthesized and evaluated. Solution aggregation studies suggested that both the number of hydrophobic arms and the length of the hydrophobic domain impact AM micelle sizes, whereas stereochemistry impacts micelle stability. 2l, the meso analogue of 2b, elicited the highest reported oxLDL uptake inhibition values (89%), highlighting the crucial effect of stereochemistry on biological properties. This study suggests that stereochemistry plays a critical role in modulating oxLDL uptake and must be considered when designing biomaterials for potential cardiovascular therapies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23795777      PMCID: PMC3773991          DOI: 10.1021/bm400537w

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  24 in total

Review 1.  The macrophage foam cell as a target for therapeutic intervention.

Authors:  Andrew C Li; Christopher K Glass
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

2.  Cell targeting by a generic receptor-targeted polymer nanocontainer platform.

Authors:  Pavel Broz; Samantha M Benito; Cheeloong Saw; Peter Burger; Harald Heider; Matthias Pfisterer; Stephan Marsch; Wolfgang Meier; Patrick Hunziker
Journal:  J Control Release       Date:  2005-02-02       Impact factor: 9.776

Review 3.  Low density lipoprotein oxidation and its pathobiological significance.

Authors:  D Steinberg
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

4.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition.

Authors:  J L Goldstein; Y K Ho; S K Basu; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

Review 5.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.

Authors:  M S Brown; J L Goldstein
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

Review 6.  Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis.

Authors:  M P de Winther; K W van Dijk; L M Havekes; M H Hofker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

7.  Growth stimulation and epidermal growth factor receptor induction in cyclooxygenase-overexpressing human colon carcinoma cells.

Authors:  Tanihiro Yoshimoto; Yoshitaka Takahashi; Takahiro Kinoshita; Toshiki Sakashita; Hiroyasu Inoue; Tadashi Tanabe
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

8.  Binding of proteins to copolymers of varying hydrophobicity.

Authors:  J Y Gao; P L Dubin
Journal:  Biopolymers       Date:  1999-02       Impact factor: 2.505

9.  Carbohydrate composition of amphiphilic macromolecules influences physicochemical properties and binding to atherogenic scavenger receptor A.

Authors:  Sarah Hehir; Nicole M Plourde; Li Gu; Dawanne E Poree; William J Welsh; Prabhas V Moghe; Kathryn E Uhrich
Journal:  Acta Biomater       Date:  2012-07-24       Impact factor: 8.947

10.  2,4-Bis(octadecanoylamino)benzenesulfonic acid sodium salt as a novel scavenger receptor inhibitor with low molecular weight.

Authors:  Kazuya Yoshiizumi; Fumio Nakajima; Rika Dobashi; Noriyasu Nishimura; Shoji Ikeda
Journal:  Bioorg Med Chem Lett       Date:  2004-06-07       Impact factor: 2.823

View more
  8 in total

Review 1.  Designing polymers with sugar-based advantages for bioactive delivery applications.

Authors:  Yingyue Zhang; Jennifer W Chan; Alysha Moretti; Kathryn E Uhrich
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

2.  Tartaric acid-based amphiphilic macromolecules with ether linkages exhibit enhanced repression of oxidized low density lipoprotein uptake.

Authors:  Dalia S Abdelhamid; Yingyue Zhang; Daniel R Lewis; Prabhas V Moghe; William J Welsh; Kathryn E Uhrich
Journal:  Biomaterials       Date:  2015-03-07       Impact factor: 12.479

3.  Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.

Authors:  Daniel R Lewis; Latrisha K Petersen; Adam W York; Kyle R Zablocki; Laurie B Joseph; Vladyslav Kholodovych; Robert K Prud'homme; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

4.  Micellar and structural stability of nanoscale amphiphilic polymers: Implications for anti-atherosclerotic bioactivity.

Authors:  Yingyue Zhang; Qi Li; William J Welsh; Prabhas V Moghe; Kathryn E Uhrich
Journal:  Biomaterials       Date:  2016-01-06       Impact factor: 12.479

5.  Carbohydrate-derived amphiphilic macromolecules: a biophysical structural characterization and analysis of binding behaviors to model membranes.

Authors:  Adriana A T Martin; Michael Tomasini; Vladyslav Kholodovych; Li Gu; Sven Daniel Sommerfeld; Kathryn E Uhrich; N Sanjeeva Murthy; William J Welsh; Prabhas V Moghe
Journal:  J Funct Biomater       Date:  2015-04-08

Review 6.  The Multifaceted Uses and Therapeutic Advantages of Nanoparticles for Atherosclerosis Research.

Authors:  Nicholas DiStasio; Stephanie Lehoux; Ali Khademhosseini; Maryam Tabrizian
Journal:  Materials (Basel)       Date:  2018-05-08       Impact factor: 3.623

Review 7.  Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential.

Authors:  Lin Di; Andrei Maiseyeu
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

8.  Impact of hydrophobic chain composition on amphiphilic macromolecule antiatherogenic bioactivity.

Authors:  Allison Faig; Latrisha K Petersen; Prabhas V Moghe; Kathryn E Uhrich
Journal:  Biomacromolecules       Date:  2014-08-06       Impact factor: 6.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.